⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL788853 | 0.79 | — | — | |
| SCHEMBL7053536 | 0.67 | — | — | |
| SCHEMBL315517 | 0.67 | — | — | |
| SCHEMBL27884552 | 0.67 | — | — | |
| SCHEMBL3187920 | 0.67 | — | — | |
| SCHEMBL6846493 | 0.66 | — | — | |
| SCHEMBL10076564 | 0.65 | — | — | |
| SCHEMBL6078579 | 0.64 | — | — | |
| SCHEMBL6356245 | 0.64 | — | — | |
| SCHEMBL10689959 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0923574-A1 | FUSED INDOLECARBOXAMIDES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORPORATION (US) | 1999-06-23 | — | — | EP | claimed |
| EP-0891354-A1 | N-AMINOALKYLDIBENZOFURANCARBOXAMIDES AS DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORPORATION (US) | 1999-01-20 | — | — | EP | claimed |
| EP-0888332-A1 | N-AMINOALKYLDIBENZOTHIOPHENECARBOXAMIDES; DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORPORATION (US) | 1999-01-07 | — | — | EP | claimed |
| EP-0888320-A1 | NOVEL N-AMINOALKYL-2-ANTHRACENECARBOXAMIDES; NEW DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORPORATION (US) | 1999-01-07 | — | — | EP | claimed |
| EP-0873329-A1 | NOVEL N-AMINOALKYLFLUORENECARBOXAMIDES; A NEW CLASS OF DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORPORATION (US) | 1998-10-28 | — | — | EP | claimed |
| WO-1998006717-A9 | FUSED INDOLECARBOXAMIDES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | — | 1998-07-23 | — | — | WO | claimed |
| WO-1998006717-A1 | FUSED INDOLECARBOXAMIDES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORPORATION (US) | 1998-02-19 | — | — | WO | claimed |
| WO-1997034884-A1 | NOVEL N-AMINOALKYL-2-ANTHRACENECARBOXAMIDES; NEW DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORPORATION (US) | 1997-09-25 | — | — | WO | claimed |
| WO-1997034889-A1 | N-AMINOALKYLDIBENZOTHIOPHENECARBOXAMIDES; DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORPORATION (US) | 1997-09-25 | — | — | WO | claimed |
| WO-1997031916-A1 | N-AMINOALKYLDIBENZOFURANCARBOXAMIDES AS DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORPORATION (US) | 1997-09-04 | — | — | WO | claimed |
| WO-1997010229-A1 | NOVEL N-AMINOALKYLFLUORENECARBOXAMIDES; A NEW CLASS OF DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORPORATION (US) | 1997-03-20 | — | — | WO | claimed |
| EP-1021425-A1 | N-AMINOALKYL-2-ANTHRAQUINONECARBOXAMIDES; DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORPORATION (US) | 2000-07-26 | — | — | EP | disclosed |
| EP-0923574-A1 | FUSED INDOLECARBOXAMIDES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORPORATION (US) | 1999-06-23 | — | — | EP | disclosed |
| EP-0891354-A1 | N-AMINOALKYLDIBENZOFURANCARBOXAMIDES AS DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORPORATION (US) | 1999-01-20 | — | — | EP | disclosed |
| EP-0888320-A1 | NOVEL N-AMINOALKYL-2-ANTHRACENECARBOXAMIDES; NEW DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORPORATION (US) | 1999-01-07 | — | — | EP | disclosed |
| WO-1997038989-A1 | N-AMINOALKYL-2-ANTHRAQUINONECARBOXAMIDES; NEW DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORPORATION (US) | 1997-10-23 | — | — | WO | disclosed |
| WO-1997034889-A1 | N-AMINOALKYLDIBENZOTHIOPHENECARBOXAMIDES; DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORPORATION (US) | 1997-09-25 | — | — | WO | disclosed |
| WO-1997034884-A1 | NOVEL N-AMINOALKYL-2-ANTHRACENECARBOXAMIDES; NEW DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORPORATION (US) | 1997-09-25 | — | — | WO | disclosed |
| WO-1997031916-A1 | N-AMINOALKYLDIBENZOFURANCARBOXAMIDES AS DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORPORATION (US) | 1997-09-04 | — | — | WO | disclosed |
| WO-1997010229-A1 | NOVEL N-AMINOALKYLFLUORENECARBOXAMIDES; A NEW CLASS OF DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORPORATION (US) | 1997-03-20 | — | — | WO | disclosed |